| |
| |
|
| Insider
Information: |
Van Naarden Jacob |
| Relationship: |
EVP & Pres., Loxo@Lilly |
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,147 |
|
|
Indirect Shares
|
4,342 |
|
|
| Direct
Value |
$11,843,986 |
|
|
|
Indirect Value
|
$3,184,900 |
|
|
| Total
Shares |
20,489 |
|
|
| Total
Value |
$15,028,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
Chief Operating Officer |
2019-02-15 |
0 |
2017-08-14 |
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
EVP & Pres., Loxo@Lilly |
2024-02-12 |
16,147 |
2024-02-12 |
4,342 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP & Pres., Loxo@Lilly |
• – – |
2024-02-12 |
4 |
A |
$737.26 |
$1,746,569 |
D/D |
2,369 |
16,147 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres., Loxo@Lilly |
• – – |
2024-02-01 |
4 |
D |
$645.61 |
$1,087,853 |
D/D |
(1,685) |
13,778 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres., Loxo@Lilly |
• – – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,618 |
15,463 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
• – – |
2023-02-16 |
4 |
D |
$335.01 |
$440,203 |
D/D |
(1,314) |
11,845 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
• – – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,785 |
13,159 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
• – – |
2023-02-10 |
4 |
A |
$345.12 |
$830,704 |
D/D |
2,407 |
10,374 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONC |
• – – |
2022-02-16 |
4 |
D |
$243.84 |
$533,034 |
D/D |
(2,186) |
7,967 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONC |
• – – |
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,461 |
10,153 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONCO |
• – – |
2021-09-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,342 |
|
% |
|
| LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONCO |
• – – |
2021-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,692 |
|
% |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Operating Officer |
• – – |
2019-02-15 |
4 |
D |
$235.00 |
$4,465,000 |
D/D |
(19,000) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-12-11 |
4 |
OE |
$3.65 |
$87,051 |
D/D |
11,500 |
20,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-12-11 |
4 |
AS |
$134.74 |
$618,080 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-12-10 |
4 |
AS |
$130.59 |
$601,434 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-12-10 |
4 |
OE |
$13.67 |
$61,515 |
D/D |
4,500 |
18,200 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-11-27 |
4 |
AS |
$138.08 |
$637,481 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-11-27 |
4 |
OE |
$3.65 |
$37,031 |
D/D |
4,500 |
18,200 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-11-26 |
4 |
AS |
$151.71 |
$842,224 |
D/D |
(5,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-11-26 |
4 |
OE |
$3.65 |
$20,064 |
D/D |
5,500 |
19,200 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-10-04 |
4 |
OE |
$3.65 |
$16,416 |
D/D |
4,500 |
18,200 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-10-04 |
4 |
AS |
$160.62 |
$731,884 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-10-03 |
4 |
AS |
$165.13 |
$919,378 |
D/D |
(5,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-10-03 |
4 |
OE |
$3.65 |
$20,064 |
D/D |
5,500 |
19,200 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-09-13 |
4 |
AS |
$165.45 |
$746,903 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-09-13 |
4 |
OE |
$3.65 |
$16,416 |
D/D |
4,500 |
18,200 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
